Showing 21 - 40 results of 1,400 for search '(( 50 ((nn decrease) OR (a decrease)) ) OR ((( 1 10 decrease ) OR ( a step decrease ))))*', query time: 0.23s Refine Results
  1. 21
  2. 22
  3. 23
  4. 24
  5. 25
  6. 26

    A computational approach for investigating the mutational landscape of RAC-alpha serine/threonine-protein kinase (AKT1) and screening inhibitors against the oncogenic E17K mutation... by Thirumal Kumar, D

    Published 2019
    “…We also performed a virtual screening analysis with 19 AKT inhibitors obtained from the Selleck Chemicals website those satisfied the Lipinski rule of 5. …”
    Get full text
    Get full text
  7. 27

    Structural analysis of missense mutations in galactokinase 1 (GALK1) leading to galactosemia type-2. by P, Sneha

    Published 2018
    “…Molecular docking analysis revealed a decrease in interaction between the protein and ATP in all the 3 mutations, and molecular dynamic simulations of 50 ns showed a loss of stability and compactness in the mutant proteins. …”
    Get full text
    Get full text
  8. 28
  9. 29
  10. 30
  11. 31
  12. 32
  13. 33
  14. 34

    Molecular properties prediction, anticancer and anti-inflammatory activities of some pyrimido[1,2-b]pyridazin-2-one derivatives by Zeiz, Ali

    Published 2023
    “…Compound 1 also induced a statistically significant decrease in the gene expression of various cytokines and chemokines. …”
    Get full text
    Get full text
  15. 35
  16. 36
  17. 37

    The Expression of TBC1 Domain Family, Member 4 (TBC1D4) in Skeletal Muscles of Insulin-Resistant Mice in Response to Sulforaphane by Rizk, Nasser M

    Published 2020
    “…Sulforaphane (SFN) has been suggested as a new potential anti-diabetic compound acting by reducing blood glucose levels through mechanisms not fully understood (1). …”
    Get full text
    Get full text
  18. 38
  19. 39
  20. 40

    Novel potentials of the DPP-4 inhibitor sitagliptin against ischemia-reperfusion (I/R) injury in rat ex-vivo heart model by Al-Awar A.

    Published 2018
    “…Findings show that Sitg (50 mg) resulted in significant decrease in IS and DPP-4 activity, and significant increase in GLP-1, NOS activity, e-NOS expression, TRPV-1 level and TRPC-1 expression, compared to controls. …”
    Get full text
    Get full text